In January, Robert F. Kennedy, Jr. bragged about having met with President-Elect Donald Trump about chairing a presidential commission on vaccine safety. In the intervening eight months, no commission has materialized, but, if you can believe his account, Kennedy has been meeting with government officials to promote his antivaccine views at the behest of the Trump administration. As long as that continues, pro-science advocates can't afford to rest easy.
Tag: NIH
In which I am compared to Donald Trump by a pro-quackademic medicine activist…again!
John Weeks has long been an activist for alternative medicine—excuse me, “complementary and alternative medicine” (CAM) or, as it’s more commonly referred to these days, “integrative medicine.” Despite his having zero background in scientific research or the design and execution of experiments and clinical trials, for some bizarre reason in May he was appointed editor of the Journal of Alternative and Complementary Medicine (JACM). It didn’t take him long at all to use his new post to launch a nasty broadside against CAM critics in general (such as yours truly) and those who criticized a sloppily done systematic review article …
The 21st Century Cures Act: Still alive, and still poised to endanger patients
it was less than a year ago that I described a bill wending its way through Congress called the 21st Century Cures Act “old vinegary wine in a new bottle.” The reason I characterized the bill that way was because it really was nothing new and it rested on a very old fallacy, namely that the only way to speed up medical “innovation” is to weaken the FDA and its standards for drug and medical device approval, which is exactly what the 21st Century Cures Act would do if passed into law. It’s basically the American cousin to the British …
The “myth” of basic science?
I’m a clinician, but I’m actually also a translational scientist. It’s not uncommon for those of us in medicine involved in some combination of basic and clinical research to argue about exactly what that means. The idea is translational science is supposed to be the process of “translating” basic science discoveries into the laboratory into medicine, be it in the form of drugs, treatments, surgical procedures, laboratory tests, diagnostic tests, or anything else that physicians use to diagnose and treat human disease. Trying to straddle the two worlds, to turn discoveries in basic science into usable medicine, is more difficult …
NIH funding: The dreaded issue of conformity rears its ugly head again
For all the worship of “translational” research that is currently in vogue, it needs to be remembered that a robust pipeline of basic science progress upon which to base translational research and clinical trials is absolutely essential if progress in medicine is to continue. Without it, progress in SBM will slow and even grind to a halt. That’s why, in the U.S., the National Institutes of Health (NIH) is so critical. The NIH funds large amounts of biomedical research each year, which means that what the NIH will and will not fund can’t help but have a profound effect shaping …